Effect of Vaginal Sildenafil on Female Sexual Function Index and Sexual Satisfactio
Phase 2
- Conditions
- Female Sexual Dysfunction and Satisfaction.
- Registration Number
- IRCT2013112015461N1
- Lead Sponsor
- Vice chancellor for research, Tarbiyat Modares Univercity
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
45-65 years old in post menopause and 25-45 years old in premenstrual women; Being sexually active; at least 12 month amenorah in post menopause women; no surgical menopause; no hormone replacement therapy; BMI= 19.8-30; no high BP; no drug use;no smoking; no alcohol; no liver; heart; thyroid disease or diabetic; no chronic disease; no cancer or precancerous disease; no vaginal bleeding;no endometrial hyperplasia or polyp; no pelvic radiation.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of female sexual satisfaction and sexual function. Timepoint: Three months after the intervention. Method of measurement: Complete Sexual Function Questionnaire (FSFI) and Sexual Satisfaction (ISS) before and after intervention.
- Secondary Outcome Measures
Name Time Method Effect on Endometrial Thickening and Interaepitelial Maturation Index in Menopause Women. Timepoint: Three Months after the Intervention. Method of measurement: Vaginal Sonography and Pap smear.